Pharmacological properties of indirubin and its derivatives

Biomed Pharmacother. 2022 Jul:151:113112. doi: 10.1016/j.biopha.2022.113112. Epub 2022 May 20.

Abstract

Background: Indirubin is the main bioactive component of the traditional Chinese medicine Indigo naturalis and is a bisindole alkaloid. Multiple studies have shown that indirubin exhibits good anticancer, anti-inflammatory and neuroprotective properties.

Methods: The purpose of this review is to provide a summary of the pharmacological mechanisms of indirubin and its derivatives.

Results: Indirubin and its derivatives exert anticancer effects by regulating the expression of cyclin-dependent kinases (CDKs), GSK-3β, Bax, Bcl-2, C-MYC, matrix metalloproteinases (MMPs), and focal adhesion kinase (FAK) through the PI3K/AKT/mTOR, nuclear factor (NF)-κB, mitogen-activated protein kinase (MAPK), JAK/signal transducer and activator of transcription 3 (STAT3) pathways and other signaling pathways. We also reviewed the anti-inflammatory and neuroprotective properties of indirubin and its derivatives.

Conclusion: The findings of recent studies assessing indirubin and its derivatives suggest that these compounds can be used as potential drugs to treat tumors, inflammation, neuropathy and bacterial infection.

Keywords: Anti-inflammation; Anticancer; Derivative; Indirubin; Pharmacology.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Glycogen Synthase Kinase 3 beta
  • Indoles* / pharmacology
  • Indoles* / therapeutic use
  • NF-kappa B / metabolism
  • Phosphatidylinositol 3-Kinases*

Substances

  • Anti-Inflammatory Agents
  • Indoles
  • NF-kappa B
  • Glycogen Synthase Kinase 3 beta
  • indirubin